enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Carbamazepine - Wikipedia

   en.wikipedia.org/wiki/Carbamazepine

   Carbamazepine, sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain. [ 4 ] [ 1 ] It is used as an adjunctive treatment in schizophrenia along with other medications and as a second-line agent in bipolar disorder .

3. List of psychotropic medications - Wikipedia

   en.wikipedia.org/wiki/List_of_psychotropic...

   Tegretol (carbamazepine) – an anticonvulsant used as a mood stabilizer; Trilafon (perphenazine)- an antipsychotic used to treat schizophrenia; Tranxene, Novo-Clopate (clorazepate) – a benzodiazepine with anxiolytic, anticonvulsant, sedative, hypnotic, and skeletal muscle relaxant properties

4. Your Guide to the 6 Most Common Types of Depression ... - AOL

   www.aol.com/6-types-depression-medications...

   Medications for Depression: An Overview. Antidepressants are a class of medications used very commonly to treat depression. In fact, nearly 13 percent of people 12 and over in the U.S. used ...

5. List of psychiatric medications by condition treated - Wikipedia

   en.wikipedia.org/wiki/List_of_psychiatric...

   INN Common brand names Carbamazepine: Carbatrol, Carnevix, Epitol, Equetro, Tegretol, Tegretol XR, Teril Gabapentin: Neurontin Lamotrigine: Lamictal

6. List of drugs known for off-label use - Wikipedia

   en.wikipedia.org/wiki/List_of_drugs_known_for...

   Carbamazepine, or Tegretol, has been used as a mood stabilizer and is accepted treatment for bipolar disorder. [6] Clomiphene (Clomid) for male infertility: clomiphene is approved for female infertility due to ovulatory disorder. Clonidine (Catapres) for ADHD: clonidine is approved and commonly used for the treatment of hypertension. Other off ...

7. For those with treatment-resistant depression, vagus nerve ...

   www.aol.com/news/those-treatment-resistant...

   With treatment-resistant depression affecting about 30% of an estimated 21 million adults with major depressive disorder, the findings are “really promising,” Badran said.